Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dreyer

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Biophotonics|December 16, 2011
Potentially malignant lesions of the upper aerodigestive tractThomas Dreyer, Melanie Kreisel
European Urology|October 24, 2025
Reply to Behzad Jazayeri, Xuefeng Wang, and Roger Li's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Thomas Dreyer, Jørgen Bjerggaard Jensen
European Urology|September 26, 2025
Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Thomas Dreyer, Jørgen Bjerggaard Jensen
European Urology|June 25, 2025
Reply to Xin Rui, Xiaoming Xu, and Bo Dai's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.03.018Thomas Dreyer, Jørgen Bjerggaard Jensen
Scandinavian Journal of Urology|December 16, 2021
Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safetyThomas Dreyer, Andreas Ernst, Jørgen Bjerggaard Jensen
Ultrasonics|August 16, 2006
Modeling of interaction between therapeutic ultrasound propagation and cavitation bubblesMarko Liebler, Thomas Dreyer, Rainer E Riedlinger
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|June 10, 2025
Histotripsy: A novel non-invasive ultrasound technology for precision thrombolysis in acute ischemic stroke managementAmeer E Hassan, Thomas Dreyer, Yousef Khalili
The Laryngoscope|August 1, 2002
Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesionsKarin Malzahn, Thomas Dreyer, Hiltrud Glanz, et al.
The Annals of Otology, Rhinology, and Laryngology|February 25, 2003
Compact endoscopy of the larynxChristoph Arens, Hiltrud Glanz, Thomas Dreyer, et al.
Archiv Fur Kriminologie|September 2, 2005
[The death of Kaspar Hauser (17 Dec 1833)--assassination, suicide or self-inflicted injury?]Manfred Risse, Christine Bartsch, Thomas Dreyer, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Biophotonics|December 16, 2011
Potentially malignant lesions of the upper aerodigestive tractThomas Dreyer, Melanie Kreisel
European Urology|October 24, 2025
Reply to Behzad Jazayeri, Xuefeng Wang, and Roger Li's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Thomas Dreyer, Jørgen Bjerggaard Jensen
European Urology|September 26, 2025
Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Thomas Dreyer, Jørgen Bjerggaard Jensen
European Urology|June 25, 2025
Reply to Xin Rui, Xiaoming Xu, and Bo Dai's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.03.018Thomas Dreyer, Jørgen Bjerggaard Jensen
Scandinavian Journal of Urology|December 16, 2021
Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safetyThomas Dreyer, Andreas Ernst, Jørgen Bjerggaard Jensen
Ultrasonics|August 16, 2006
Modeling of interaction between therapeutic ultrasound propagation and cavitation bubblesMarko Liebler, Thomas Dreyer, Rainer E Riedlinger
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|June 10, 2025
Histotripsy: A novel non-invasive ultrasound technology for precision thrombolysis in acute ischemic stroke managementAmeer E Hassan, Thomas Dreyer, Yousef Khalili
The Laryngoscope|August 1, 2002
Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesionsKarin Malzahn, Thomas Dreyer, Hiltrud Glanz, et al.
The Annals of Otology, Rhinology, and Laryngology|February 25, 2003
Compact endoscopy of the larynxChristoph Arens, Hiltrud Glanz, Thomas Dreyer, et al.
Archiv Fur Kriminologie|September 2, 2005
[The death of Kaspar Hauser (17 Dec 1833)--assassination, suicide or self-inflicted injury?]Manfred Risse, Christine Bartsch, Thomas Dreyer, et al.
Pageof 4